Conferences are held on Mondays, 12–1 p.m., via Teams unless noted. Core curriculum lectures are in bold.
| Date | Topic | Speaker |
|---|---|---|
| Aug. 31 | LDL-C-lowering medications and guidelines | Vijay Nambi |
| Sept. 14 | Cardiometabolic disease: why the time to focus is now | Layla Abushamat |
| Sept. 21 | Journal Club | Thomas Tsai |
| Sept. 28 | Triglycerides: what works now and what will in the future | Christie Ballantyne |
| Oct. 5 | HDL: current relevance in CVD (part 1) | Baiba Gillard |
| Oct. 12 | HDL: current relevance in CVD (part 2) | Henry Pownall |
| Oct. 19 | Journal Club | Thomas Tsai |
| Oct. 26 | Hypertension management | Addison Taylor |
| Nov. 2 | AHA prep | Open |
| Nov. 16 | AHA review | Thomas Tsai |
| Nov. 30 | Cardiovascular risk stratification | José Rivas |
| Dec. 7 | Metabolomics and proteomics | Bing Yu |
| Jan. 11 | Management of inflammation in CVD prevention | Christie Ballantyne |
| Jan. 25 | Journal Club | Thomas Tsai |
| Feb. 1 | Weight loss strategies | Layla Abushamat |
| Feb. 8 | Biomarkers and CVD | Ron Hoogeveen |
| Feb. 15 | Macrophages, monocytes, and CVD | Huaizhu Wu |
| Feb. 22 | Lipoprotein(a) | Anandita Kulkarni |
| March 1 | CAC scoring, CT scanning, and atherosclerosis | Mahmoud Al Rifai |
| March 8 | Pediatric lipid management | Justin Zachariah |
| March 15 | Aging, brain health, and atherosclerosis | Anum Saeed |
| March 22 | Women and cardiovascular disease | Mini Varughese |
| March 29 | Residual risk | Vijay Nambi |
| April 5 | ACC prep | Open |
| April 19 | ACC review | Thomas Tsai |
| April 26 | Journal Club | Thomas Tsai |
| May 3 | Make up | |
| May 10 | Year in review: my research | Thomas Tsai |